CoChat

Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Changes in D(2) receptors during antidepressant therapy have been reported in patients with major depressive disorder using PET/SPET. The aim of this study was to evaluate modifications in D(2) receptors that might occur in patients affected by obsessive-compulsive disorder (OCD) during serotonin reuptake sites inhibitors (SSRIs). To this purpose, we measured the in vivo binding of [(11)C]raclopride ([(11)C]Rac)in the brain of a group of OCD naïve patients before and after the repeated administration of the inhibitor SSRI fluvoxamine. Eight patients with a Diagnostic and Statistical Manual of Mental Disorders IVth edition diagnosis of OCD completed the study undergoing a PET scan and a complete clinical evaluation before and during treatment with fluvoxamine. Patients have been compared also with a group of nine age-matched normal volunteers. Fluvoxamine treatment significantly improved clinical symptoms and increased [(11)C]Rac binding potential (BP) in the basal ganglia of OCD patients (7.5+/-5.2, 6.9+/-6.9, and 9.9+/-9.3% in dorsal caudate, dorsal putamen, and ventral basal ganglia, respectively; p<0.01) to values closer to those observed in the group of normal subjects. Chronic treatment with fluvoxamine induces a slight but significant increase in striatal [(11)C]Rac BP of previously drug-naïve OCD patients. The modifications in D(2) receptor availability might be secondary to fluvoxamine effects on serotoninergic activity.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1301199

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Cited by

See all 73

Metadata

Authors
Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., & Fazio, F.
Affiliations
  • Institute of Molecular Bioimaging and Physiology (IT)
  • IRCCS Ospedale San Raffaele (IT)
  • Vita-Salute San Raffaele University (IT)
Corresponding author
Moresco, Rosa Maria
Venue
Neuropsychopharmacology
Published
2006-10-04
Volume
32
Issue
1
Pages
197-205
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2048998525
Cited by
70
References
51
Citations by year
2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 3
FWCI
5.90
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
obsessive-compulsive disorder, fluvoxamine, dopamine D2 receptor, serotonin reuptake inhibitors, [11C]raclopride, basal ganglia, drug-naive patients
MeSH terms
Adult, Basal Ganglia, Brain Mapping, Carbon Isotopes, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Protein Binding, Tissue Distribution, Fluvoxamine, Selective Serotonin Reuptake Inhibitors, Receptors, Dopamine D2, Dopamine Antagonists, Raclopride, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients. https://app.cochat.ai/papers/10.1038/sj.npp.1301199
The paper
Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., & Fazio, F. (2007). Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1301199

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.